Passive Adverse Event Approach Is Key Facet Of US FDA's Right-To-Try Rule

 
• By Sarah Karlin-Smith
  
rules and regulations marked on rubber stamp
FDA outlines annual reporting requirements for right-to-try in new proposed rule • Source: Shutterstock

More from Drug Safety

More from Pink Sheet